Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Karnes

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Urology|September 22, 2021
Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical CystectomyT Miest, A Khanna, V Sharma, et al.
European Urology|January 26, 2016
Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical ProstatectomyStephen J Freedland, Voleak Choeurng, Lauren Howard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 28, 2015
Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancerStephen J Murphy, Robert J Karnes, Farhad Kosari, et al.
Oncogene|September 27, 2016
Cell cycle-coupled expansion of AR activity promotes cancer progressionC McNair, A Urbanucci, C E S Comstock, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 31, 2025
Defining NECTIN4 Amplification and Protein Expression in Urothelial Carcinoma and Histologic SubtypesJohn C Cheville, Jacob J Orme, Sounak Gupta, et al.
Urologic Oncology|September 19, 2016
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancerJ Alfred Witjes, Guido Dalbagni, Robert J Karnes, et al.
Prostate Cancer and Prostatic Diseases|November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysisB Benzon, S G Zhao, M C Haffner, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2016
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic riskA E Ross, R B Den, K Yousefi, et al.
Actas Urologicas Espanolas|June 20, 2021
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patientsF Pisano, P Gontero, R Sylvester, et al.
World Journal of Urology|May 4, 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thoughtJ Palou, F Pisano, R Sylvester, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Urology|September 22, 2021
Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical CystectomyT Miest, A Khanna, V Sharma, et al.
European Urology|January 26, 2016
Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical ProstatectomyStephen J Freedland, Voleak Choeurng, Lauren Howard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 28, 2015
Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancerStephen J Murphy, Robert J Karnes, Farhad Kosari, et al.
Oncogene|September 27, 2016
Cell cycle-coupled expansion of AR activity promotes cancer progressionC McNair, A Urbanucci, C E S Comstock, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 31, 2025
Defining NECTIN4 Amplification and Protein Expression in Urothelial Carcinoma and Histologic SubtypesJohn C Cheville, Jacob J Orme, Sounak Gupta, et al.
Urologic Oncology|September 19, 2016
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancerJ Alfred Witjes, Guido Dalbagni, Robert J Karnes, et al.
Prostate Cancer and Prostatic Diseases|November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysisB Benzon, S G Zhao, M C Haffner, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2016
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic riskA E Ross, R B Den, K Yousefi, et al.
Actas Urologicas Espanolas|June 20, 2021
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patientsF Pisano, P Gontero, R Sylvester, et al.
World Journal of Urology|May 4, 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thoughtJ Palou, F Pisano, R Sylvester, et al.
Pageof 8